Fulgent Oncology
Fred Daugherty currently serves as the Chief Operating Officer at CSI Laboratories, a position held since 2011, where responsibilities include overseeing daily operations and leading strategic planning initiatives. Prior to this role, Fred held various positions at CSI Laboratories, including Senior Laboratory Operations Manager and Flow Cytometry Manager, overseeing the Flow Cytometry Laboratory and managing a team of medical technologists. Fred's career began as a Flow Cytometry Analyst at Ameripath from February 2005 to May 2007. Fred holds a Bachelor of Science degree in Medical Technology from Georgia State University, which was obtained between 1988 and 1990.
This person is not in any teams
This person is not in any offices
Fulgent Oncology
As a brand under Fulgent Genetics, Fulgent Oncology provides personalized cancer diagnostics services through CSI Laboratories and Inform Diagnostics, Fulgent Genetics subsidiaries. Together, our labs have helped pathologists and oncologists accurately diagnose and treat their patients for over 25 years. Our in-house medical team works closely with pathologists, oncologists and technicians to provide comprehensive diagnostic testing and analysis throughout the United States and Caribbean. We invest in an expert medical team, the right technology and equipment, and training to provide a higher level of service to customers. Our testing services include: Flow Cytometry, FISH, Cytogenetic Analysis, Histology and Molecular Genetics. We also provide hematopathology and surgical pathology consultations and second opinions to support diagnosis and treatment decisions. We understand the need to deliver accurate and fast test results and we are driven every day by our mission to provide personalized cancer diagnostics to support pathologists in providing care to cancer patients.